| A European evidence-based guideline for the prevention of type 2 diabetes B Paulweber, P Valensi, J Lindström, NM Lalic, CJ Greaves, M McKee, ... Hormone and Metabolic research 42 (S 01), S3-S36, 2010 | 675 | 2010 |
| Take action to prevent diabetes–the IMAGE toolkit for the prevention of type 2 diabetes in Europe J Lindström, A Neumann, KE Sheppard, A Gilis-Januszewska, ... Hormone and Metabolic research 42 (S 01), S37-S55, 2010 | 310 | 2010 |
| Delaying progression to type 2 diabetes among high-risk Spanish individuals is feasible in real-life primary healthcare settings using intensive lifestyle intervention B Costa, F Barrio, JJ Cabré, JL Pinol, X Cos, C Solé, B Bolíbar, J Basora, ... Diabetologia 55, 1319-1328, 2012 | 168 | 2012 |
| Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: a meta-analysis K Khunti, A Ceriello, X Cos, C De Block Diabetes research and clinical practice 137, 137-148, 2018 | 164 | 2018 |
| Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus WD Strain, X Cos, M Hirst, S Vencio, V Mohan, Z Vokó, D Yabe, M Blüher, ... Diabetes research and clinical practice 105 (3), 302-312, 2014 | 135 | 2014 |
| Association of general and abdominal obesity with hypertension, dyslipidemia and prediabetes in the PREDAPS Study FJ Sangrós, J Torrecilla, C Giraldez-Garcia, L Carrillo, J Mancera, T Mur, ... Revista Española de Cardiología (English Edition) 71 (3), 170-177, 2018 | 86 | 2018 |
| Deintensification in older patients with type 2 diabetes: a systematic review of approaches, rates and outcomes S Seidu, SK Kunutsor, P Topsever, CE Hambling, FX Cos, K Khunti Diabetes, Obesity and Metabolism 21 (7), 1668-1679, 2019 | 75 | 2019 |
| SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: a systematic review and meta-analysis S Seidu, SK Kunutsor, X Cos, S Gillani, K Khunti Primary Care Diabetes 12 (3), 265-283, 2018 | 73 | 2018 |
| Quality indicators for the prevention of type 2 diabetes in Europe–IMAGE P Pajunen, R Landgraf, F Muylle, A Neumann, J Lindström, PE Schwarz, ... Hormone and metabolic research 42 (S 01), S56-S63, 2010 | 72 | 2010 |
| Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use … JM Polinski, SC Kim, D Jiang, A Hassoun, WH Shrank, X Cos, ... BMC endocrine disorders 15, 1-9, 2015 | 61 | 2015 |
| A disease state approach to the pharmacological management of type 2 diabetes in primary care: a position statement by Primary Care Diabetes Europe S Seidu, X Cos, S Brunton, SB Harris, SPO Jansson, M Mata-Cases, ... Primary Care Diabetes 15 (1), 31-51, 2021 | 54 | 2021 |
| Prevalence of diabetic retinopathy and its relationship with glomerular filtration rate and other risk factors in patients with type 2 diabetes mellitus in Spain. DM2 HOPE study M López, FX Cos, F Álvarez-Guisasola, E Fuster Journal of clinical & translational endocrinology 9, 61-65, 2017 | 51 | 2017 |
| Asociación de obesidad general y abdominal con hipertensión, dislipemia y presencia de prediabetes en el estudio PREDAPS FJ Sangrós, J Torrecilla, C Giráldez-García, L Carrillo, J Mancera, T Mur, ... Revista Española de Cardiología 71 (3), 170-177, 2018 | 50 | 2018 |
| Indirect impact of the COVID-19 pandemic on hospitalisations for cardiometabolic conditions and their management: A systematic review S Seidu, SK Kunutsor, X Cos, K Khunti Primary care diabetes 15 (4), 653-681, 2021 | 41 | 2021 |
| Factors influencing safe glucose-lowering in older adults with type 2 diabetes: A PeRsOn-centred ApproaCh To IndiVidualisEd (PROACTIVE) Glycemic Goals for older people: A … CE Hambling, K Khunti, X Cos, J Wens, L Martinez, P Topsever, ... Primary care diabetes 13 (4), 330-352, 2019 | 38 | 2019 |
| miR-10b and miR-223-3p in serum microvesicles signal progression from prediabetes to type 2 diabetes M Parrizas, X Mundet, C Castaño, S Canivell, X Cos, L Brugnara, ... Journal of endocrinological investigation 43 (4), 451-459, 2020 | 37 | 2020 |
| 2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care S Seidu, X Cos, S Brunton, SB Harris, SPO Jansson, M Mata-Cases, ... Primary Care Diabetes 16 (2), 223-244, 2022 | 33 | 2022 |
| Trends in chronic complications of type 2 diabetic patients from Spanish primary health care centres (GEDAPS study): ten year-implementation of St. Vincent recommendations X Mundet, F Cano, M Mata-Cases, P Roura, J Franch, M Birules, ... Primary care diabetes 6 (1), 11-18, 2012 | 32 | 2012 |
| Screening for people with abnormal glucose metabolism in the European DE-PLAN project FX Cos, NC Barengo, B Costa, X Mundet-Tudurí, J Lindström, ... Diabetes research and clinical practice 109 (1), 149-156, 2015 | 31 | 2015 |
| for and on behalf of Primary Care Diabetes Europe. SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: a systematic review and meta-analysis S Seidu, SK Kunutsor, X Cos, S Gillani, K Khunti Prim Care Diabetes 12 (3), 265-283, 2018 | 29 | 2018 |
